Patent Application: Iron Metabolism Targets for Obesity Treatment
Summary
The USPTO has published a new patent application (US20260085321A1) detailing methods for treating obesity by inhibiting specific iron metabolism genes. The application, filed on September 24, 2025, by inventor Richard Possemato, proposes inducing weight loss through increased lipid catabolism.
What changed
This document is a published patent application from the USPTO, specifically application US20260085321A1, filed on September 24, 2025. It outlines methods for treating obesity and related disorders by inhibiting the expression or function of NFS1, BOLA3, IBA57, or NFU1, or a combination thereof. The proposed mechanism involves inducing a metabolic shift that promotes weight loss by increasing lipid catabolism.
As this is a patent application, it does not impose immediate regulatory obligations or penalties on entities. However, it signals potential future developments in obesity treatment and related intellectual property. Companies involved in pharmaceutical research and development, particularly in metabolic disorders and drug discovery, should be aware of this filing for competitive intelligence and potential licensing opportunities.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
IRON METABOLISM TARGETS FOR OBESITY
Application US20260085321A1 Kind: A1 Mar 26, 2026
Inventors
Richard Possemato
Abstract
Provided are methods for promoting weight loss and treating and reducing risk of developing obesity related disorders. The methods involve inhibiting expression or function of NFS1, BOLA3, IBA57, or NFU1, or a combination thereof. The methods induce a metabolic shift that causes weight loss in part by increasing lipid catabolism.
CPC Classifications
C12N 15/1137 A61P 3/04 C12N 2310/14 C12N 2310/531
Filing Date
2025-09-24
Application No.
19338714
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.